content top

Clinical Experience of Ocriplasmin for Vitreomacular Traction and MH

Posted by , , , , , , , and on Apr 28, 2016 in Intravitreal injection, Vitreomacular traction

Purpose: To evaluate the anatomical and functional results after ocriplasmin (JETREA, ThromboGenics NV, Iselin, NJ, USA) injection in patients with vitreomacular traction (VMT) with or without macular hole (MH). Methods: Fifteen prospective patients with VMT were treated with a single ocriplasmin injection and followed-up at baseline, 1 week, 1, 3 and 6 months. ETDRS best-corrected visual acuity (BCVA), intraocular pressure and...

Read More

Comparison of the Effect of Ranibizumab and Aflibercept for Choroidal Thickness Changes in Wet AMD

Posted by , , and on Apr 27, 2016 in ARMD, Intravitreal injection

SCIENTIFIC POSTER 2016_Comparison of the Effect of Ranibizumab and Aflibercept for Choroidal Thickness Changes in Wet AMD Hee Seong Yoon Purpose: To compare the changes in subfoveal choroidal thickness (SFCT) after intravitreal ranibizumab or aflibercept injections for neovascular age-related macular degeneration (nAMD). Methods: Medical records of 67 treatment-naive patients (69 eyes) who were diagnosed with neovascular AMD (nAMD) and...

Read More

Simple Repositioning of Migrated Dexamethasone Implant Without Surgical Intervention

Posted by and on Apr 27, 2016 in Intravitreal injection

SCIENTIFIC POSTER 2016_Simple Repositioning of Migrated Dexamethasone Implant Without Surgical Intervention Yong-Sok Ji Purpose: To report a simple method to manage the dexamethasone implant migrated into the anterior chamber in a patient with a previous intraocular lens scleral fixation via vitrectomy. Methods: A 64-year-old man presented with a sudden reduction of visual acuity of his right eye after dexamethasone implant injection for...

Read More

Outcome of IVT of Ocriplasmin for Symptomatic Vitreomacular Adhesion

Posted by and on Apr 27, 2016 in Intravitreal injection, Vitreomacular traction

SCIENTIFIC POSTER 2016_Outcome of IVTY of Ocriplasmin for Symptomatic Vitreomacular Adhesion Mostafa Elgohary Purpose: To evaluate the rate of release of vitreomacular adhesion (VMA), anatomical changes and visual outcome following intravitreal ocriplasmin injection for the treatment of symptomatic VMA with and without full-thickness macular hole (FTMH). Methods: This is a retrospective, interventional, case-series of 12 eyes of 11...

Read More

Results of Intravitreal Aflibercept in Insufficient Responders to Prior Anti-VEGF Therapy in Neovascular AMD

Posted by , , , and on Apr 27, 2016 in ARMD, Intravitreal injection

SCIENTIFIC POSTER 2016_Results of Intravitreal Aflibercept in Insufficient Responders to Prior Anti-VEGF Therapy in Neovascular AMD Zeynep Alkin Purpose: To report the outcomes of intravitreal aflibercept therapy in eyes with refractory neovascular age-related macular degeneration (AMD) switched from intravitreal bevacizumab or ranibizumab. Methods: This is a retrospective review of eyes with neovascular AMD switched to intravitreal...

Read More

Safety and Efficacy of Intravitreal Preservative-free Triamcinolone for ME Secondary to Diabetes or Retinal Vein Occlusion

Posted by , , , and on Apr 23, 2016 in Central retinal vein occlusion, Intravitreal injection, Macular Edema

Purpose: To evaluate the efficacy and safety of preservative-free triamcinolone acetonide injectable suspension (Taioftal) for the treatment of macular edema secondary to diabetes or retinal vein occlusion. Design, Setting & Participants: From January 2015 to December 2015, at Ospedale Maggiore of Bologna, a retrospective study was conducted on patients suffering from macular edema secondary to diabetes or retinal vein occlusion....

Read More
content top